$EBS
Emergent Biosolutions, Inc.
XNYS•Health Care•Pharmaceutical Preparations
$6.80
▼-3.13%-$0.220
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEmergent Biosolutions, Inc.
XNYS•Health Care•Pharmaceutical Preparations
Why is EBS down today? It is at $6.80 (-3.13%), and our scanner flagged it 44 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EBS spikes, and full due diligence on EBS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $EBS 44 times in the last 30 days. Create a free account to track $EBS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on EBS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EBS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KRegulation FD DisclosureSep 14, 2026 · 5 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Williams Paul Anthony Officer | Sold (automatic/other) | -3K | sold 1.9% | 159K | $25K at $8.40 | Jul 1, 26 |
Hartzel William Officer | Sold (automatic/other) | -2K | sold 0.9% | 186K | $14K at $8.00 | Jun 8, 26 |
Glessner Coleen Officer | Sold (automatic/other) | -2K | sold 1.0% | 202K | $16K at $8.00 | Jun 8, 26 |
Lindahl Richard S Officer | Sold (automatic/other) | -4K | sold 1.0% | 374K | $32K at $8.00 | Jun 8, 26 |
Williams Paul Anthony Officer | Sold (automatic/other) | -694 | sold 0.4% | 162K | $6K at $8.00 | Jun 8, 26 |
Zoon Kathryn C Director | Sold (automatic/other) | -17K 0.03% of company | sold 18% | 80K | $144K at $8.36 | May 1, 26 |
Degolyer Donald W Director | Sold (automatic/other) | -15K 0.03% of company | sold 11% | 130K | $129K at $8.36 | May 1, 26 |
Dayal Sujata Tyagi Director | Sold (automatic/other) | -14K 0.03% of company | sold 12% | 101K | $115K at $8.36 | May 1, 26 |
Harsanyi Zsolt Officer | Acquired (grant/award) | +25K 0.05% of company | added 20% | 149K | n/a | Apr 30, 26 |
Fowler Neal Franklin Director | Acquired (grant/award) | +25K 0.05% of company | added 19% | 161K | n/a | Apr 30, 26 |
Zoon Kathryn C Director | Acquired (grant/award) | +25K 0.05% of company | added 35% | 97K | n/a | Apr 30, 26 |
Richard Ronald Director | Acquired (grant/award) | +25K 0.05% of company | added 26% | 124K | n/a | Apr 30, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on EBS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EBS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
EBS last traded at $6.80, down 3.13% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Emergent Biosolutions, Inc. (EBS) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The EBS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EBS 44 times in the last 30 days.
EBS (Emergent Biosolutions, Inc.) trades on XNYS, with a market cap of about $349M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EBS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$EBS discussion
Sign in to ask a question or join the discussion.